THE STORY
Drug development often optimizes the machinery before asking whether the machinery is necessary.
A conventional plan can accumulate sites, vendors, monitoring layers, visits, labs and contractual delay before anyone isolates the uncertainty that actually controls the decision. Our starting assumption is the opposite: every dollar and every day has to defend its existence.
Cheap does not win by itself. Fast does not win by itself. A path wins only if its answer is scientifically credible, operationally realistic and usable by the regulator that matters.
FAQ
The boundaries matter.
What exactly am I buying for $4,950?
A bounded research and diligence sprint on one defined asset/indication question. The output is a sourced decision memo and scorecard, not a guarantee of development success.
Will you find assets for me?
The initial sprint can assess a defined opportunity. Broader asset sourcing can follow under a separate written engagement, including success-based structures where appropriate and lawful.
Can you run the company around an asset?
Potentially, after diligence. The virtual-biotech model means assembling only the people and infrastructure required for the next evidence milestone. It is not part of the initial sprint.
How do you stop cheap from becoming reckless?
Safety, scientific validity, rights, data integrity, regulatory usability and accountable human review are gates, not optimization targets.
What if my question is out of scope after I pay?
We reconcile payment and confirm scope before research begins. If we cannot accept the defined diligence question as purchased, we will offer a revised scope or refund the diligence sprint rather than silently begin different work.
Do I need an account?
No. This is a concierge professional service, not SaaS. Your Stripe receipt plus your paid-intake reference identify the engagement. If repeat or multi-project work later makes a portal useful, we can add one without forcing account friction on a one-off sprint.
How do I send private or large files?
Submit the intake first. During scope confirmation we provide an appropriate transfer path for private or large source packages. Do not paste confidential patient information into the public intake form.
When will I receive the memo?
We target scope confirmation within 1 business day and the decision memo within 5 business days after complete inputs are received. Complex data rooms or unusually broad questions are re-scoped before work begins.
